Systemic antifungal prescribing in neonates and children: outcomes from the Antibiotic Resistance and Prescribing in European Children (ARPEC) Study

• Published in: Antimicrobial agents and chemotherapy Vol. 59; no. 2; pp. 782 - 789
• Main Authors: Lestner, J M, Versporten, A, Doerholt, K, Warris, A, Roilides, E, Sharland, M, Bielicki, J, Goossens, H
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 01.02.2015
• Subjects: Adolescent; Amphotericin B; Amphotericin B - administration & dosage; Amphotericin B - therapeutic use; Antifungal Agents; Antifungal Agents - administration & dosage; Antifungal Agents - therapeutic use; Child; Child, Preschool; Clinical Therapeutics; Deoxycholic Acid; Deoxycholic Acid - administration & dosage; Deoxycholic Acid - therapeutic use; Drug Combinations; Fluconazole - administration & dosage; Fluconazole - therapeutic use; Hospitals; Humans; Infant; Infant, Newborn

The appropriate use of systemic antifungals is vital in the prevention and treatment of invasive fungal infection (IFI) in immunosuppressed children and neonates. This multicenter observational study describes the inpatient prescribing practice of antifungal drugs for children and neonates and ident...